DiaSorin S.p.A. (DSRLF)

R&D Expenses

€103.71M

TTM · Period ending: · EUR

DSRLF logo

DSRLF R&D Expenses

Latest reported€103.71M EUR
DSRLF TTM R&D Expenses · EUR (€16.07M → €103.71M)
High-resolution chart · PNG

DSRLF r&d expenses history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

DiaSorin S.p.A. R&D Expenses — Trailing twelve months (TTM) (EUR)
Period endingR&D Expenses (EUR)
103,711,985
79,987,342
103,987,342
96,772,000
95,772,000
93,800,000
91,800,000
88,180,000
88,180,000
90,002,000
91,302,000
93,659,000
96,959,000
97,792,000
96,892,000
97,379,000
92,879,000
80,491,000
70,091,000
57,100,000
48,800,000
50,400,000
50,800,000
51,548,000
50,148,000
48,651,000
47,951,000
46,085,000
46,185,000
45,114,000
45,114,000
44,759,000
44,259,000
45,100,000
43,600,000
43,091,000
42,591,000
40,742,000
37,724,000
34,140,000
30,194,000
27,293,000
26,158,000
25,365,000
25,288,000
25,105,000
24,994,000
24,789,000
24,136,000
23,873,000
23,947,000
23,762,000
23,823,000
23,928,000
23,393,000
23,081,000
22,524,000
21,740,000
21,481,000
21,420,000
21,389,000
20,506,000
19,332,000
18,336,000
17,074,000
16,333,000
16,074,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.